OBI cohort funds $700,000 for neurotech start-ups
May 18, 2022
TORONTO – The Ontario Brain Institute (OBI) is pleased to announce the inaugural NERVE cohort, a group of seven entrepreneurs funded through Canada’s single largest award for early-stage neurotechnology development.
Formerly known as the Ontario Neurotech Entrepreneurship (ONtrepreneurs) program, the NERVE Program (Neurotech Entrepreneurship to Validate Emerging Innovations) provides $100,000 in funding to each of the Canadian-based entrepreneurs.
Read More
VANCOUVER – Taking innovative research from concept to application is critical for improving healthcare systems and the well-being of patients. The Vancouver Coastal Health Research Institute is proud to support investigators and their ground-breaking health research with the Innovation and Translational Research Awards. This year’s recipients are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities.
KITCHENER, Ont. – The Ontario Ministry of Health announced it will invest $1 million in a study at Grand River Hospital to evaluate the use of an intraoperative surgical technology that could improve outcomes for patients who require hip replacement surgery. The study will inform the development of a new pathway to improve the adoption of new medical innovations that will innovate patient care in hospitals across the province.
MONTREAL – The Research Institute of the McGill University Health Centre (RI-MUHC), the McGill University Health Centre (MUHC) Foundation with Boehringer Ingelheim (Canada) Ltd., HOP Tech, and MEDTEQ+ are proud to announce a new, three-year partnership to research and develop artificial intelligence-based technology to better screen for and identify type 2 diabetes mellitus (T2DM) in people 35 and up with cardiovascular risk factors, such as high blood pressure and heart disease.
EDMONTON – DrugBank has secured $9 million in seed funding to solve the challenges associated with the world’s exponentially-growing biomedical data. This seed round was led by Brightspark Ventures with participation from Amplitude Ventures, Theodorus Investment Funds and existing investors including AccelerateFund and BoxOne Ventures who led the pre-seed round.
BURLINGTON, Ont. – Boehringer Ingelheim (Canada) Ltd., a leading research-driven biopharmaceutical company, announced a new five-year strategic partnership with the Vector Institute, an independent, not-for-profit corporation driving research excellence and leadership in artificial intelligence (AI) to foster economic growth and improve the lives of Canadians.
TORONTO – Walter Wodchis (pictured), PhD, a professor at the University of Toronto’s Institute of Health Policy, Management and Evaluation, has been awarded a grant from the Canadian Institutes of Health Research (CIHR) worth nearly $1.5 million to lead a national study identifying strategies for successful implementation of primary health care teams.
HALIFAX – Ten Dalhousie researchers will share close to $6 million in Canadian Institutes of Health Research (CIHR) funding designed to elevate ideas with the greatest potential to improve human health. The new research supported through the Project Grants Fall 2021 competition will focus on topics such as counteracting hearing and sight loss, exploring the causes of epilepsy and intellectual disability, incorporating Indigenous knowledge into medical practices, and creating a better understanding of what influences our mental health.
TORONTO – DNAstack has announced Viral AI, a federated network for genomic variant surveillance and infectious disease research. Viral AI was designed to deliver equitable access to software infrastructure, accelerate international data sharing, and empower scientists and public health officials with globally representative datasets they need to mitigate current and future infectious disease outbreaks.
LONDON, Ont. – A new study from Lawson Health Research Institute will be the first to explore Canadian Veterans’ beliefs about confidentiality in mental health care and whether those beliefs act as a barrier to seeking treatment for a type of trauma known as moral injury.